Common genetic variation in IGF1, IGFBP1 and IGFBP3 and ovarian cancer risk

Carcinogenesis

Volumn 30, Issue 12, 2009, Pages 2042-2046

  Terry, Kathryn L ^a,b   Tworoger, Shelley S ^a,b   Gates, Margaret A ^a,b   Cramer, Daniel W ^a,b   Hankinson, Susan E ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ARTICLE; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; ADULT; AGED; BIOSYNTHESIS; BLOOD; GENETICS; GENOTYPE; MIDDLE AGED; OVARY TUMOR; REGRESSION ANALYSIS; RISK;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; GENETIC VARIATION; GENOTYPE; HAPLOTYPES; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; ODDS RATIO; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; REGRESSION ANALYSIS; RISK;

EID: 73949126110     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp257     Document Type: Article

References (26)

1. Khandwala, H.M. et al. (2000) The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr. Rev., 21, 215-244.
2. Resnicoff, M. et al. (1993) Insulin-like growth factor-1 and its receptor mediate the autocrine proliferation of human ovarian carcinoma cell lines. Lab. Invest., 69, 756-760.
3. Chakrabarty, S. et al. (2006) Insulin-like growth factor binding protein-2 stimulates proliferation and activates multiple cascades of the mitogenactivated protein kinase pathways in NIH-OVCAR3 human epithelial ovarian cancer cells. Cancer Biol. Ther., 5, 189-197.
4. Lee, E.J. et al. (2005) Insulin-like growth factor binding protein 2 promotes ovarian cancer cell invasion. Mol. Cancer, 4, 7.
5. Lukanova, A. et al. (2002) Circulating levels of insulin-like growth factor-I and risk of ovarian cancer. Int. J. Cancer, 101, 549-554.
6. Peeters, P.H. et al. (2007) Serum IGF-I, its major binding protein (IGFBP-3) and epithelial ovarian cancer risk: the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr. Relat. Cancer, 14, 81-90.
7. Lukanova, A. et al. (2003) Risk of ovarian cancer in relation to prediagnostic levels of C-peptide, insulin-like growth factor binding proteins-1 and -2 (USA, Sweden, Italy). Cancer Causes Control, 14, 285-292.
8. Tworoger, S.S. et al. (2007) Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of incident ovarian cancer. Cancer Epidemiol. Biomarkers Prev., 16, 783-788.
9. Patel, A.V. et al. (2008) IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings fromthe Breast and Prostate Cancer Cohort Consortium (BPC3). PLoS ONE, 3, e2578.
10. Terry, K.L. et al. (2005) Genetic variation in the progesterone receptor gene and ovarian cancer risk. Am. J. Epidemiol., 161, 442-451.
11. Hankinson, S.E. et al. (1995) Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J. Natl. Cancer Inst., 87, 1297-1302.
12. Gates, M.A. et al. (2007) A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer. Int. J. Cancer, 121, 2225-2232.
13. Gates, M.A. et al. (2008) Talc use, variants of the GSTM1, GSTT1, and NAT2 genes, and risk of epithelial ovarian cancer. Cancer Epidemiol. Biomarkers Prev., 17, 2436-2444.
14. Tamimi, R.M. et al. (2007) Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study. Breast Cancer Res., 9, R18.
15. Cheng, I. et al. (2006) Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort. Cancer Epidemiol. Biomarkers Prev., 15, 1993-1997.
16. Cheng, I. et al. (2006) Common genetic variation in IGF1 and prostate cancer risk in the Multiethnic Cohort. J. Natl. Cancer Inst., 98, 123-134.
17. Stram, D.O. et al. (2003) Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multiethnic Cohort Study. Hum. Hered., 55, 27-36.
18. Gabriel, S.B. et al. (2002) The structure of haplotype blocks in the human genome. Science, 296, 2225-2229.
19. Tworoger, S.S. et al. (2007) Insulin-like growth factors and ovarian cancer risk: a nested case-control study in three cohorts. Cancer Epidemiol. Biomarkers Prev., 16, 1691-1695.
20. Excoffier, L. et al. (1995) Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population. Mol. Biol. Evol., 12, 921-927.
21. Zaykin, D.V. et al. (2002) Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum. Hered., 53, 79-91.
22. DerSimonian, R. et al. (1986) Meta-analysis in clinical trials. Control Clin. Trials, 7, 177-188.
23. Wacholder, S. et al. (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J. Natl. Cancer Inst., 96, 434-442.
24. Rosner, B. (1983) Percentage points for a generalized ESD many-outlier procedure. Technometrics, 25, 165-172.
25. Al-Zahrani, A. et al. (2006) IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer. Hum. Mol. Genet., 15, 1-10.
26. Missmer, S.A. et al. (2006) Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2-to 3-year period. Cancer Epidemiol. Biomarkers Prev., 15, 972 978.